IL153679A0 - Polycyclic xanthone derivatives and pharmaceutical compositions containing the same - Google Patents

Polycyclic xanthone derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL153679A0
IL153679A0 IL15367901A IL15367901A IL153679A0 IL 153679 A0 IL153679 A0 IL 153679A0 IL 15367901 A IL15367901 A IL 15367901A IL 15367901 A IL15367901 A IL 15367901A IL 153679 A0 IL153679 A0 IL 153679A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
alkyl
hydrogen
Prior art date
Application number
IL15367901A
Other languages
English (en)
Original Assignee
Inst Biomar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biomar Sa filed Critical Inst Biomar Sa
Publication of IL153679A0 publication Critical patent/IL153679A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mold Materials And Core Materials (AREA)
IL15367901A 2000-06-29 2001-06-29 Polycyclic xanthone derivatives and pharmaceutical compositions containing the same IL153679A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016020.0A GB0016020D0 (en) 2000-06-29 2000-06-29 New polyciclic xanthones and their use
PCT/GB2001/002898 WO2002000663A2 (fr) 2000-06-29 2001-06-29 Nouveaux xanthones polycycliques et leur utilisation

Publications (1)

Publication Number Publication Date
IL153679A0 true IL153679A0 (en) 2003-07-06

Family

ID=9894705

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15367901A IL153679A0 (en) 2000-06-29 2001-06-29 Polycyclic xanthone derivatives and pharmaceutical compositions containing the same
IL153679A IL153679A (en) 2000-06-29 2002-12-26 History of polycyclic xanthone and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153679A IL153679A (en) 2000-06-29 2002-12-26 History of polycyclic xanthone and pharmaceutical preparations containing them

Country Status (21)

Country Link
US (1) US6812245B2 (fr)
EP (1) EP1296989B1 (fr)
JP (1) JP2004501924A (fr)
KR (1) KR100801068B1 (fr)
CN (1) CN1273470C (fr)
AT (1) ATE362935T1 (fr)
AU (2) AU2001266206B2 (fr)
BR (1) BR0112090A (fr)
CA (1) CA2412559A1 (fr)
CY (1) CY1106805T1 (fr)
DE (1) DE60128565T2 (fr)
DK (1) DK1296989T3 (fr)
ES (1) ES2287135T3 (fr)
GB (1) GB0016020D0 (fr)
HK (1) HK1052707B (fr)
IL (2) IL153679A0 (fr)
MX (1) MXPA03000199A (fr)
NZ (1) NZ523338A (fr)
PT (1) PT1296989E (fr)
RU (1) RU2285008C2 (fr)
WO (1) WO2002000663A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101372538B (zh) 2007-08-21 2012-08-29 北京万和芯源生物技术有限公司 紫外光辅助的表面改性方法及具有由此方法形成的表面的制品
WO2009085360A2 (fr) * 2007-10-04 2009-07-09 Novobiotic Pharmaceuticals Llc Antibiotique à base de citreamicine doté d'un résidu glucidique
WO2009085359A2 (fr) * 2007-10-04 2009-07-09 Novobiotic Pharmaceuticals Llc Antibiotique à base de citreamicine isolé du gendre nocardia
CN101889998B (zh) * 2010-05-28 2012-10-03 暨南大学 一种组合物及其在制备tr3受体诱导剂中的应用
HRP20231233T1 (hr) 2017-04-27 2024-01-19 Pharma Mar, S.A. Antitumorski spojevi
CN107619803B (zh) * 2017-09-19 2020-03-03 浙江大学 一种暗黄链霉酸和暗黄链霉酮的制备及其医药用途
CN109320527B (zh) * 2018-11-12 2020-08-28 中国医学科学院医药生物技术研究所 鹿色霉素(cervinomycin)B1、B2、B3、B4及其生产方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57102897A (en) 1980-12-17 1982-06-26 Kitasato Inst:The Antibiotic am-5344-a2 and its preparation
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPH0755951B2 (ja) 1986-02-17 1995-06-14 北里研究所(社団法人) セルビノマイシン系抗生物質誘導体およびその製造法
JPS62270587A (ja) 1986-05-16 1987-11-24 Taiho Yakuhin Kogyo Kk 4181−2物質及びそのアシル誘導体
AU599650B2 (en) * 1986-05-16 1990-07-26 Taiho Pharmaceutical Co., Ltd. Substance 4181-2 and its derivatives
JPS62270527A (ja) 1986-05-16 1987-11-24 Taiho Yakuhin Kogyo Kk 4181−2物質及びその誘導体を有効成分とする抗腫瘍剤
EP0353381A3 (fr) 1988-08-04 1991-01-02 American Cyanamid Company L'antibiotique LL-E 19085 alpha
US5223430A (en) * 1988-08-04 1993-06-29 American Cyanamid Company Subspecies of micromonospora citrea which produces antibiotic ll-e19085 alpha
US5096907A (en) * 1989-06-29 1992-03-17 American Cyanamid Company Antibiotic LL-E19085
EP0405151A1 (fr) 1989-06-29 1991-01-02 American Cyanamid Company Antibiotique LL-E19085
EP0442003A1 (fr) 1990-02-13 1991-08-21 American Cyanamid Company Antibiotique LL-E 19085 alpha
GB0011927D0 (en) 2000-05-17 2000-07-05 Inst Biomar Sa New use of citreamicins

Also Published As

Publication number Publication date
CA2412559A1 (fr) 2002-01-03
CN1449399A (zh) 2003-10-15
AU6620601A (en) 2002-01-08
DE60128565D1 (en) 2007-07-05
ES2287135T3 (es) 2007-12-16
EP1296989A2 (fr) 2003-04-02
CN1273470C (zh) 2006-09-06
ATE362935T1 (de) 2007-06-15
JP2004501924A (ja) 2004-01-22
US6812245B2 (en) 2004-11-02
KR100801068B1 (ko) 2008-02-04
EP1296989B1 (fr) 2007-05-23
WO2002000663A2 (fr) 2002-01-03
DE60128565T2 (de) 2008-01-17
RU2285008C2 (ru) 2006-10-10
KR20030034117A (ko) 2003-05-01
WO2002000663A3 (fr) 2002-05-30
NZ523338A (en) 2005-07-29
PT1296989E (pt) 2007-08-29
DK1296989T3 (da) 2007-09-24
HK1052707A1 (en) 2003-09-26
MXPA03000199A (es) 2004-02-26
HK1052707B (en) 2007-09-21
IL153679A (en) 2008-06-05
US20040009928A1 (en) 2004-01-15
CY1106805T1 (el) 2012-05-23
AU2001266206B2 (en) 2006-08-10
GB0016020D0 (en) 2000-08-23
BR0112090A (pt) 2003-05-06

Similar Documents

Publication Publication Date Title
HU9403842D0 (en) Compounds useful as sweeting a gents and process for their preparation
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
GEP19981299B (en) Method of Preparing Taxane Derivatives
PL344048A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
CA2475113A1 (fr) Derives isothiazole utiles en tant qu'agents anticancereux
IL60861A0 (en) Compound obtained from microorganisms of the genus streptomyces, process for the preparation thereof and process for the preparation of anthelmintic and acaricidal compositions containing it
PL344183A1 (en) Metabolites of ecteinascidin 743
IL153679A0 (en) Polycyclic xanthone derivatives and pharmaceutical compositions containing the same
AU2001225432A1 (en) Novel podophyllotoxin compositions
EP1437359A3 (fr) Nouveaux 3,6-Hemicetals appartenant à la classe des 9a-Azalides
Rho et al. A novel monogalactosylacylglycerol with inhibitory effect on platelet aggregation from the cyanophyceae Oscillatoria rosea
CA2191850A1 (fr) Inhibiteur de la metastase cancereuse
AU3284699A (en) Process for the preparation of simvastatin and derivatives thereof
TR200200300T2 (tr) İshali önlemeye elverişli bifidobakteriler.
WO2001051004A3 (fr) Agent anticancereux contenant un compose naphtoquinone
EP1346994A4 (fr) Inhibiteurs de la biosynthese du cholesterol contenant comme principe actif des composes spiro tricycliques
WO2006012490A3 (fr) Saccharides cetogenes
CA2113404A1 (fr) Derives 17,20-epoxydes du pregnane, leur preparation, leur application a la preparation de derives cortisoniques et intermediaires
NZ511728A (en) Substances WK-5344A and WK-5344B obtained from microorganisms of the genus Streptomyces
AU2003294031A1 (en) Dust-free pigment compositions obtainable by spray-drying
MY115430A (en) Glutaramide derivatives.
ATE181103T1 (de) Kdo-aldolase und kondensationsreaktion damit
CA2362903A1 (fr) Nouveaux derives du sulfofucosylacylglycerol et leur utilisation comme medicaments
AU7582396A (en) Synthesis of carboxylic acid derivatives
EP0751130A4 (fr) Derives de la 4,5-dihydropyrazole-5-thione et acaricide les contenant

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted